Diagnostic Uncertainties and Delayed Treatment Protocols Impact Efficacy of FMT for Clostridioides difficile Infection
- 22 April 2025
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (3) , e60-e61
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- A Randomized Controlled Trial of Efficacy and Safety of Fecal Microbiota Transplant for Preventing Recurrent Clostridioides difficile InfectionClinical Infectious Diseases, 2024
- AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies for Select Gastrointestinal DiseasesGastroenterology, 2024
- SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile InfectionNew England Journal of Medicine, 2022
- High risk of post‐infectious irritable bowel syndrome in patients with Clostridium difficile infectionAlimentary Pharmacology & Therapeutics, 2016